Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases

JTO Clinical and Research Reports（2022）

引用 1|浏览22

暂无评分

摘要

Our study represents the most comprehensive genomic characterization of NSCLC-BM available to date, paving the way to functional studies aimed at assessing the potential of the identified pathogenic alterations as clinical biomarkers and targets.

查看译文

关键词

Non–small cell lung cancer (NSCLC),Brain metastases,Genomic profiling,Targetable pathogenic alterations

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要